Strona główna・Stock List・Inspire Medical Systems Inc

Inspire Medical Systems Inc

Open

SectorHealthcare

53.11 5.65

Buy Sell

Overview

Share price change

24h

Current

Min

50.49

Max

50.55

Key metrics
By Trading Economics
Income	-147M -11M
Sales	-64M 205M
P/E Sector Avg	11.753 60.149
EPS	0.1
Profit margin	-5.52
Employees	1,333
EBITDA	-42M 7.5M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	-1.88% downside

Dividends
By Acuity
Next Earnings	3 sie 2026

Market Stats
By TradingEconomics
Market Cap	-99M 1.5B
Previous open	47.46
Previous close	53.11

News Sentiment

By Acuity

91%

4 / 340 Ranking in Healthcare

Inspire Medical Systems Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 lip 2026, 18:01 UTC

Inspire Medical Systems shares are higher today amid broader market volatility, influenced by rising yields and oil prices surpassing $90 per barrel.

Peer Comparison

Price change

Inspire Medical Systems Inc Forecast

Price Target

By TipRanks

-1.88% downside

12 Months Forecast

Average 52.27 USD -1.88%

High 65 USD

Low 39 USD

Based on 13 Wall Street analysts offering 12 month price targets forInspire Medical Systems Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

13 ratings

Buy

Hold

Sell

Based on 13 analysts giving stock ratings to Inspire Medical Systems Inc - Dist in the past 3 months.

Sentiment

By Acuity

4 / 340 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.